+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Microneedle Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 269 Pages
  • June 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5916002
The global microneedle drug delivery systems market is poised for significant growth, fueled by increasing demand for minimally invasive drug delivery methods. These advanced systems are gaining widespread attention due to their ability to enhance drug absorption, improve patient compliance, and reduce pain associated with traditional injections. According to the latest analysis by the publisher, the market is anticipated to grow from US$ 7.3 billion in 2025 to US$ 11 billion by 2032, expanding at a steady CAGR of 6.03%.

Market Insights

Microneedle drug delivery systems utilize micron-scale needles to deliver drugs intradermally or transdermally, bypassing conventional hypodermic injection challenges. They are widely used in dermatology, oncology, neurology, and vaccine delivery, among other medical applications. The ongoing technological advancements and growing awareness about non-invasive treatment options are expected to be key growth contributors.

Key Market Drivers

Several factors are driving the demand for microneedle drug delivery systems:

  • Rising demand for painless drug administration: Patients are increasingly favoring non-invasive drug delivery methods that reduce pain and discomfort. Microneedles eliminate the fear and complications associated with traditional needles.
  • Expansion in vaccine administration: The global rise in vaccine-preventable diseases such as measles, combined with efforts to simplify vaccination through easy-to-use microneedle patches, has significantly boosted market penetration.
  • Growing chronic disease burden: With increasing incidences of conditions such as diabetes and cancer, the need for frequent, safe, and efficient drug delivery systems is becoming critical.
  • Favorable regulatory support: Innovations in microneedle technology, including FDA clearances and CE markings for intradermal drug delivery systems, are facilitating faster adoption.

Business Opportunity

The microneedle drug delivery systems market presents immense opportunities for innovation in terms of product design, drug formulations, and personalized medicine. Manufacturers are increasingly investing in research and development to design cost-effective and scalable solutions. Self-administration, especially in rural and remote areas, is expected to further propel the adoption of these systems.

Emerging applications such as hormone replacement therapy, pain management, and cosmetic treatments are widening the scope of microneedle systems beyond traditional uses. The integration of 3D printing and advanced biomaterials in microneedle manufacturing is also opening new avenues for growth.

Regional Analysis

North America remains the dominant region in the global microneedle drug delivery systems market. High healthcare spending, favorable reimbursement policies, and robust R&D infrastructure are driving demand in the region. The United States, in particular, is at the forefront due to its extensive applications in vaccine delivery, hormone therapy, and cancer treatment.

Asia Pacific is emerging as a lucrative market, owing to a rapidly growing population, increased awareness of advanced drug delivery technologies, and rising investments in healthcare infrastructure. Europe is also witnessing growth, supported by rising cosmetic and dermatology applications and an aging population that demands painless medical interventions.

Key Players

The competitive Analysis of the microneedle drug delivery systems market is marked by active innovation and strategic collaborations. Leading players include:

  • Raphas Co. Ltd.
  • Becton Dickinson and Company
  • NanoPass Technologies Limited
  • 3M
  • Zosano Pharma Corporation
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab
Notable developments include partnerships for product innovation and regulatory approvals. For instance, NanoPass Technologies’ MicronJet gained FDA approval, and Carnegie Mellon University’s 3D-printed microneedle arrays for vaccine delivery represent a technological breakthrough.

Segmentation

By Type:

  • Solid
  • Hollow
  • Dissolving
  • Coated
  • Others

By Material:

  • Silicon
  • Metal
  • Polymer
  • Others

By Application:

  • Dermatology
  • Drug Delivery
  • Pain Management
  • Cancer Therapy
  • Vaccine Delivery
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Microneedle Drug Delivery Systems Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Microneedle Drug Delivery Systems Market Outlook, 2019-2032
3.1. Global Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Mn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Solid
3.1.1.2. Hollow
3.1.1.3. Dissolving
3.1.1.4. Coated
3.1.1.5. Other Types
3.2. Global Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Mn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Silicon
3.2.1.2. Metal
3.2.1.3. Polymer
3.2.1.4. Other Materials
3.3. Global Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Mn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Dermatology
3.3.1.2. Drug Delivery
3.3.1.3. Pain Management
3.3.1.4. Cancer Therapy
3.3.1.5. Vaccine Delivery
3.3.1.6. Other Applications
3.4. Global Microneedle Drug Delivery Systems Market Outlook, by Region, Value (US$ Mn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Microneedle Drug Delivery Systems Market Outlook, 2019-2032
4.1. North America Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Mn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Solid
4.1.1.2. Hollow
4.1.1.3. Dissolving
4.1.1.4. Coated
4.1.1.5. Other Types
4.2. North America Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Mn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Silicon
4.2.1.2. Metal
4.2.1.3. Polymer
4.2.1.4. Other Materials
4.3. North America Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Mn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Dermatology
4.3.1.2. Drug Delivery
4.3.1.3. Pain Management
4.3.1.4. Cancer Therapy
4.3.1.5. Vaccine Delivery
4.3.1.6. Other Applications
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Mn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
4.4.1.2. U.S. Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
4.4.1.3. U.S. Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
4.4.1.4. Canada Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
4.4.1.5. Canada Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
4.4.1.6. Canada Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Microneedle Drug Delivery Systems Market Outlook, 2019-2032
5.1. Europe Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Mn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Solid
5.1.1.2. Hollow
5.1.1.3. Dissolving
5.1.1.4. Coated
5.1.1.5. Other Types
5.2. Europe Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Mn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Silicon
5.2.1.2. Metal
5.2.1.3. Polymer
5.2.1.4. Other Materials
5.3. Europe Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Mn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Dermatology
5.3.1.2. Drug Delivery
5.3.1.3. Pain Management
5.3.1.4. Cancer Therapy
5.3.1.5. Vaccine Delivery
5.3.1.6. Other Applications
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Mn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
5.4.1.2. Germany Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
5.4.1.3. Germany Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
5.4.1.4. U.K. Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
5.4.1.5. U.K. Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
5.4.1.6. U.K. Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
5.4.1.7. France Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
5.4.1.8. France Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
5.4.1.9. France Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
5.4.1.10. Italy Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
5.4.1.11. Italy Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
5.4.1.12. Italy Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
5.4.1.13. Turkey Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
5.4.1.14. Turkey Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
5.4.1.15. Turkey Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
5.4.1.16. Russia Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
5.4.1.17. Russia Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
5.4.1.18. Russia Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
5.4.1.19. Rest of Europe Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
5.4.1.20. Rest of Europe Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
5.4.1.21. Rest of Europe Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, 2019-2032
6.1. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Mn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Solid
6.1.1.2. Hollow
6.1.1.3. Dissolving
6.1.1.4. Coated
6.1.1.5. Other Types
6.2. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Mn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Silicon
6.2.1.2. Metal
6.2.1.3. Polymer
6.2.1.4. Other Materials
6.3. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Mn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Dermatology
6.3.1.2. Drug Delivery
6.3.1.3. Pain Management
6.3.1.4. Cancer Therapy
6.3.1.5. Vaccine Delivery
6.3.1.6. Other Applications
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Mn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
6.4.1.2. China Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
6.4.1.3. China Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
6.4.1.4. Japan Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
6.4.1.5. Japan Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
6.4.1.6. Japan Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
6.4.1.7. South Korea Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
6.4.1.8. South Korea Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
6.4.1.9. South Korea Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
6.4.1.10. India Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
6.4.1.11. India Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
6.4.1.12. India Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
6.4.1.13. Southeast Asia Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
6.4.1.14. Southeast Asia Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
6.4.1.15. Southeast Asia Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
6.4.1.16. Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
6.4.1.17. Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
6.4.1.18. Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Microneedle Drug Delivery Systems Market Outlook, 2019-2032
7.1. Latin America Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Mn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Solid
7.1.1.2. Hollow
7.1.1.3. Dissolving
7.1.1.4. Coated
7.1.1.5. Other Types
7.2. Latin America Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Mn), 2019-2032
7.2.1.1. Silicon
7.2.1.2. Metal
7.2.1.3. Polymer
7.2.1.4. Other Materials
7.3. Latin America Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Mn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Dermatology
7.3.1.2. Drug Delivery
7.3.1.3. Pain Management
7.3.1.4. Cancer Therapy
7.3.1.5. Vaccine Delivery
7.3.1.6. Other Applications
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Mn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
7.4.1.2. Brazil Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
7.4.1.3. Brazil Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
7.4.1.4. Mexico Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
7.4.1.5. Mexico Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
7.4.1.6. Mexico Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
7.4.1.7. Argentina Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
7.4.1.8. Argentina Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
7.4.1.9. Argentina Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
7.4.1.10. Rest of Latin America Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
7.4.1.11. Rest of Latin America Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
7.4.1.12. Rest of Latin America Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, 2019-2032
8.1. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Mn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Solid
8.1.1.2. Hollow
8.1.1.3. Dissolving
8.1.1.4. Coated
8.1.1.5. Other Types
8.2. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Mn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Silicon
8.2.1.2. Metal
8.2.1.3. Polymer
8.2.1.4. Other Materials
8.3. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Mn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Dermatology
8.3.1.2. Drug Delivery
8.3.1.3. Pain Management
8.3.1.4. Cancer Therapy
8.3.1.5. Vaccine Delivery
8.3.1.6. Other Applications
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Mn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
8.4.1.2. GCC Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
8.4.1.3. GCC Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
8.4.1.4. South Africa Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
8.4.1.5. South Africa Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
8.4.1.6. South Africa Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
8.4.1.7. Egypt Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
8.4.1.8. Egypt Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
8.4.1.9. Egypt Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
8.4.1.10. Nigeria Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
8.4.1.11. Nigeria Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
8.4.1.12. Nigeria Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Microneedle Drug Delivery Systems Market by Type, Value (US$ Mn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Microneedle Drug Delivery Systems Market by Material, Value (US$ Mn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Microneedle Drug Delivery Systems Market by Application, Value (US$ Mn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Distribution Channel vs by Material Heat map
9.2. Manufacturer vs by Material Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Raphas Co. Ltd.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Becton Dickinson and Company
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. NanoPass Technologies Limited
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. 3M
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Zosano Pharma Corporation
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Corium International Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Valeritas Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Nitto Denko Corporation
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Microdermics Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. TheraJect Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Raphas Co. Ltd
  • Becton Dickinson and Company
  • NanoPass Technologies Limited
  • 3M
  • Zosano Pharma Corporation
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab